Which has stronger valuation and earnings, HQY or ITGR?

HealthEquity has higher earnings, but lower revenue than Integer. HealthEquity is trading at a lower price-to-earnings ratio than Integer, indicating that it is currently the more affordable of the two stocks. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio HealthEquity $1.31B 6.49 $215.20M $2.77 37.20 Integer $1.85B 2.32 $102.81M $2.98 42.47

Is HQY or ITGR more profitable?

HealthEquity has a net margin of 17.36% compared to Integer's net margin of 5.68%. HealthEquity's return on equity of 15.33% beat Integer's return on equity. Company Net Margins Return on Equity Return on Assets HealthEquity 17.36% 15.33% 9.51% Integer 5.68% 11.84% 5.98%

Which has stronger earnings and valuation, CNC or HQY?

HealthEquity has lower revenue, but higher earnings than Centene. Centene is trading at a lower price-to-earnings ratio than HealthEquity, indicating that it is currently the more affordable of the two stocks. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Centene $194.78B 0.18 -$6.67B $2.92 24.10 HealthEquity $1.31B 6.49 $215.20M $2.77 37.20

Is CNC or HQY more profitable?

HealthEquity has a net margin of 17.36% compared to Centene's net margin of 0.72%. HealthEquity's return on equity of 15.33% beat Centene's return on equity. Company Net Margins Return on Equity Return on Assets Centene 0.72% 12.15% 3.28% HealthEquity 17.36% 15.33% 9.51%

Does the media favor CNC or HQY?

In the previous week, Centene had 7 more articles in the media than HealthEquity. MarketBeat recorded 10 mentions for Centene and 3 mentions for HealthEquity. Centene's average media sentiment score of 0.95 beat HealthEquity's score of 0.78 indicating that Centene is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Centene 6 Very Positive mention(s) 0 Positive mention(s) 3 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive HealthEquity 2 Very Positive mention(s) 0 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive

Does the media favor MOH or HQY?

In the previous week, Molina Healthcare had 2 more articles in the media than HealthEquity. MarketBeat recorded 5 mentions for Molina Healthcare and 3 mentions for HealthEquity. HealthEquity's average media sentiment score of 0.78 beat Molina Healthcare's score of 0.23 indicating that HealthEquity is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Molina Healthcare 1 Very Positive mention(s) 0 Positive mention(s) 3 Neutral mention(s) 1 Negative mention(s) 0 Very Negative mention(s) Neutral HealthEquity 2 Very Positive mention(s) 0 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive

Does the media prefer HQY or OSCR?

In the previous week, Oscar Health had 13 more articles in the media than HealthEquity. MarketBeat recorded 16 mentions for Oscar Health and 3 mentions for HealthEquity. HealthEquity's average media sentiment score of 0.78 beat Oscar Health's score of 0.59 indicating that HealthEquity is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment HealthEquity 2 Very Positive mention(s) 0 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Oscar Health 4 Very Positive mention(s) 2 Positive mention(s) 6 Neutral mention(s) 3 Negative mention(s) 0 Very Negative mention(s) Positive

Does the media favor CLOV or HQY?

In the previous week, Clover Health Investments had 8 more articles in the media than HealthEquity. MarketBeat recorded 11 mentions for Clover Health Investments and 3 mentions for HealthEquity. HealthEquity's average media sentiment score of 0.78 beat Clover Health Investments' score of 0.71 indicating that HealthEquity is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Clover Health Investments 4 Very Positive mention(s) 1 Positive mention(s) 4 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive HealthEquity 2 Very Positive mention(s) 0 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive

HealthEquity (HQY) Competitors

$103.46 +0.41 (+0.40%)

Closing price 04:00 PM Eastern

Extended Trading

$103.44 -0.02 (-0.01%)

As of 04:52 PM Eastern

Compare

HQY vs. ITGR, CNC, MOH, OSCR, and CLOV

Should you buy HealthEquity stock or one of its competitors? HealthEquity's main competitors and comparable companies include Integer (ITGR), Centene (CNC), Molina Healthcare (MOH), Oscar Health (OSCR), and Clover Health Investments (CLOV). Companies are selected based on similarities in market, industry, and size. These companies are all part of the "healthcare" sector.

How does HealthEquity compare to Integer?

HealthEquity (NASDAQ:HQY) and Integer (NYSE:ITGR) are both mid-cap healthcare companies, but which is the superior investment? We will contrast the two businesses based on the strength of their risk, institutional ownership, analyst recommendations, media sentiment, earnings, profitability, valuation and dividends.

HealthEquity has higher earnings, but lower revenue than Integer. HealthEquity is trading at a lower price-to-earnings ratio than Integer, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
HealthEquity	$1.31B	6.49	$215.20M	$2.77	37.20
Integer	$1.85B	2.32	$102.81M	$2.98	42.47

HealthEquity presently has a consensus target price of $113.53, suggesting a potential upside of 10.17%. Integer has a consensus target price of $113.67, suggesting a potential downside of 10.20%. Given HealthEquity's stronger consensus rating and higher probable upside, equities analysts clearly believe HealthEquity is more favorable than Integer.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
HealthEquity	1 Sell rating(s)	0 Hold rating(s)	11 Buy rating(s)	1 Strong Buy rating(s)	2.92
Integer	0 Sell rating(s)	11 Hold rating(s)	1 Buy rating(s)	0 Strong Buy rating(s)	2.08

HealthEquity has a net margin of 17.36% compared to Integer's net margin of 5.68%. HealthEquity's return on equity of 15.33% beat Integer's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
HealthEquity	17.36%	15.33%	9.51%
Integer	5.68%	11.84%	5.98%

In the previous week, HealthEquity had 3 more articles in the media than Integer. MarketBeat recorded 3 mentions for HealthEquity and 0 mentions for Integer. Integer's average media sentiment score of 1.76 beat HealthEquity's score of 0.78 indicating that Integer is being referred to more favorably in the news media.

Company	Overall Sentiment
HealthEquity	Positive
Integer	Very Positive

HealthEquity has a beta of 0.22, suggesting that its stock price is 78% less volatile than the broader market. Comparatively, Integer has a beta of 0.6, suggesting that its stock price is 40% less volatile than the broader market.

99.6% of HealthEquity shares are held by institutional investors. Comparatively, 99.3% of Integer shares are held by institutional investors. 1.6% of HealthEquity shares are held by company insiders. Comparatively, 1.1% of Integer shares are held by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company is poised for long-term growth.

Summary

HealthEquity beats Integer on 13 of the 17 factors compared between the two stocks.

How does HealthEquity compare to Centene?

Centene (NYSE:CNC) and HealthEquity (NASDAQ:HQY) are both healthcare companies, but which is the superior investment? We will compare the two businesses based on the strength of their media sentiment, dividends, risk, analyst recommendations, earnings, valuation, profitability and institutional ownership.

Centene presently has a consensus target price of $73.80, indicating a potential upside of 4.86%. HealthEquity has a consensus target price of $113.53, indicating a potential upside of 10.17%. Given HealthEquity's stronger consensus rating and higher possible upside, analysts plainly believe HealthEquity is more favorable than Centene.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Centene	1 Sell rating(s)	11 Hold rating(s)	9 Buy rating(s)	0 Strong Buy rating(s)	2.38
HealthEquity	1 Sell rating(s)	0 Hold rating(s)	11 Buy rating(s)	1 Strong Buy rating(s)	2.92

HealthEquity has a net margin of 17.36% compared to Centene's net margin of 0.72%. HealthEquity's return on equity of 15.33% beat Centene's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Centene	0.72%	12.15%	3.28%
HealthEquity	17.36%	15.33%	9.51%

93.6% of Centene shares are held by institutional investors. Comparatively, 99.6% of HealthEquity shares are held by institutional investors. 0.4% of Centene shares are held by insiders. Comparatively, 1.6% of HealthEquity shares are held by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company is poised for long-term growth.

HealthEquity has lower revenue, but higher earnings than Centene. Centene is trading at a lower price-to-earnings ratio than HealthEquity, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Centene	$194.78B	0.18	-$6.67B	$2.92	24.10
HealthEquity	$1.31B	6.49	$215.20M	$2.77	37.20

In the previous week, Centene had 7 more articles in the media than HealthEquity. MarketBeat recorded 10 mentions for Centene and 3 mentions for HealthEquity. Centene's average media sentiment score of 0.95 beat HealthEquity's score of 0.78 indicating that Centene is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Centene	6 Very Positive mention(s)	0 Positive mention(s)	3 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
HealthEquity	2 Very Positive mention(s)	0 Positive mention(s)	0 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

Centene has a beta of 1.07, meaning that its stock price is 7% more volatile than the broader market. Comparatively, HealthEquity has a beta of 0.22, meaning that its stock price is 78% less volatile than the broader market.

Summary

HealthEquity beats Centene on 12 of the 17 factors compared between the two stocks.

How does HealthEquity compare to Molina Healthcare?

Molina Healthcare (NYSE:MOH) and HealthEquity (NASDAQ:HQY) are both healthcare companies, but which is the better business? We will compare the two businesses based on the strength of their risk, analyst recommendations, earnings, media sentiment, dividends, profitability, institutional ownership and valuation.

Molina Healthcare currently has a consensus price target of $213.88, indicating a potential upside of 2.01%. HealthEquity has a consensus price target of $113.53, indicating a potential upside of 10.17%. Given HealthEquity's stronger consensus rating and higher probable upside, analysts plainly believe HealthEquity is more favorable than Molina Healthcare.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Molina Healthcare	2 Sell rating(s)	13 Hold rating(s)	3 Buy rating(s)	0 Strong Buy rating(s)	2.06
HealthEquity	1 Sell rating(s)	0 Hold rating(s)	11 Buy rating(s)	1 Strong Buy rating(s)	2.92

Molina Healthcare has a beta of 0.75, meaning that its share price is 25% less volatile than the broader market. Comparatively, HealthEquity has a beta of 0.22, meaning that its share price is 78% less volatile than the broader market.

In the previous week, Molina Healthcare had 2 more articles in the media than HealthEquity. MarketBeat recorded 5 mentions for Molina Healthcare and 3 mentions for HealthEquity. HealthEquity's average media sentiment score of 0.78 beat Molina Healthcare's score of 0.23 indicating that HealthEquity is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Molina Healthcare	1 Very Positive mention(s)	0 Positive mention(s)	3 Neutral mention(s)	1 Negative mention(s)	0 Very Negative mention(s)	Neutral
HealthEquity	2 Very Positive mention(s)	0 Positive mention(s)	0 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

98.5% of Molina Healthcare shares are held by institutional investors. Comparatively, 99.6% of HealthEquity shares are held by institutional investors. 1.4% of Molina Healthcare shares are held by company insiders. Comparatively, 1.6% of HealthEquity shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock is poised for long-term growth.

HealthEquity has a net margin of 17.36% compared to Molina Healthcare's net margin of -0.11%. HealthEquity's return on equity of 15.33% beat Molina Healthcare's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Molina Healthcare	-0.11%	2.50%	0.65%
HealthEquity	17.36%	15.33%	9.51%

Molina Healthcare has higher revenue and earnings than HealthEquity. Molina Healthcare is trading at a lower price-to-earnings ratio than HealthEquity, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Molina Healthcare	$45.43B	0.24	$472M	-$0.96	N/A
HealthEquity	$1.31B	6.49	$215.20M	$2.77	37.20

Summary

HealthEquity beats Molina Healthcare on 12 of the 17 factors compared between the two stocks.

How does HealthEquity compare to Oscar Health?

HealthEquity (NASDAQ:HQY) and Oscar Health (NYSE:OSCR) are both mid-cap healthcare companies, but which is the better stock? We will contrast the two companies based on the strength of their dividends, earnings, valuation, institutional ownership, risk, analyst recommendations, media sentiment and profitability.

HealthEquity has a beta of 0.22, suggesting that its stock price is 78% less volatile than the broader market. Comparatively, Oscar Health has a beta of 2.56, suggesting that its stock price is 156% more volatile than the broader market.

In the previous week, Oscar Health had 13 more articles in the media than HealthEquity. MarketBeat recorded 16 mentions for Oscar Health and 3 mentions for HealthEquity. HealthEquity's average media sentiment score of 0.78 beat Oscar Health's score of 0.59 indicating that HealthEquity is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
HealthEquity	2 Very Positive mention(s)	0 Positive mention(s)	0 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
Oscar Health	4 Very Positive mention(s)	2 Positive mention(s)	6 Neutral mention(s)	3 Negative mention(s)	0 Very Negative mention(s)	Positive

HealthEquity has higher earnings, but lower revenue than Oscar Health. Oscar Health is trading at a lower price-to-earnings ratio than HealthEquity, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
HealthEquity	$1.31B	6.49	$215.20M	$2.77	37.20
Oscar Health	$11.70B	0.84	-$443.15M	$2.42	13.14

HealthEquity currently has a consensus target price of $113.53, suggesting a potential upside of 10.17%. Oscar Health has a consensus target price of $34.60, suggesting a potential upside of 8.78%. Given HealthEquity's stronger consensus rating and higher possible upside, analysts clearly believe HealthEquity is more favorable than Oscar Health.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
HealthEquity	1 Sell rating(s)	0 Hold rating(s)	11 Buy rating(s)	1 Strong Buy rating(s)	2.92
Oscar Health	1 Sell rating(s)	7 Hold rating(s)	4 Buy rating(s)	1 Strong Buy rating(s)	2.38

99.6% of HealthEquity shares are held by institutional investors. Comparatively, 75.7% of Oscar Health shares are held by institutional investors. 1.6% of HealthEquity shares are held by company insiders. Comparatively, 22.6% of Oscar Health shares are held by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock will outperform the market over the long term.

HealthEquity has a net margin of 17.36% compared to Oscar Health's net margin of 4.90%. Oscar Health's return on equity of 49.39% beat HealthEquity's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
HealthEquity	17.36%	15.33%	9.51%
Oscar Health	4.90%	49.39%	9.29%

Summary

HealthEquity beats Oscar Health on 11 of the 16 factors compared between the two stocks.

How does HealthEquity compare to Clover Health Investments?

Clover Health Investments (NASDAQ:CLOV) and HealthEquity (NASDAQ:HQY) are both mid-cap healthcare companies, but which is the better stock? We will compare the two companies based on the strength of their valuation, earnings, institutional ownership, media sentiment, profitability, dividends, risk and analyst recommendations.

HealthEquity has a net margin of 17.36% compared to Clover Health Investments' net margin of 0.45%. HealthEquity's return on equity of 15.33% beat Clover Health Investments' return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Clover Health Investments	0.45%	4.66%	2.43%
HealthEquity	17.36%	15.33%	9.51%

19.8% of Clover Health Investments shares are held by institutional investors. Comparatively, 99.6% of HealthEquity shares are held by institutional investors. 23.5% of Clover Health Investments shares are held by insiders. Comparatively, 1.6% of HealthEquity shares are held by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company will outperform the market over the long term.

Clover Health Investments has a beta of 2.52, indicating that its stock price is 152% more volatile than the broader market. Comparatively, HealthEquity has a beta of 0.22, indicating that its stock price is 78% less volatile than the broader market.

In the previous week, Clover Health Investments had 8 more articles in the media than HealthEquity. MarketBeat recorded 11 mentions for Clover Health Investments and 3 mentions for HealthEquity. HealthEquity's average media sentiment score of 0.78 beat Clover Health Investments' score of 0.71 indicating that HealthEquity is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Clover Health Investments	4 Very Positive mention(s)	1 Positive mention(s)	4 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
HealthEquity	2 Very Positive mention(s)	0 Positive mention(s)	0 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

Clover Health Investments currently has a consensus price target of $5.10, suggesting a potential upside of 4.51%. HealthEquity has a consensus price target of $113.53, suggesting a potential upside of 10.17%. Given HealthEquity's stronger consensus rating and higher probable upside, analysts plainly believe HealthEquity is more favorable than Clover Health Investments.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Clover Health Investments	1 Sell rating(s)	3 Hold rating(s)	3 Buy rating(s)	0 Strong Buy rating(s)	2.29
HealthEquity	1 Sell rating(s)	0 Hold rating(s)	11 Buy rating(s)	1 Strong Buy rating(s)	2.92

HealthEquity has lower revenue, but higher earnings than Clover Health Investments. HealthEquity is trading at a lower price-to-earnings ratio than Clover Health Investments, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Clover Health Investments	$1.92B	1.35	-$85.55M	$0.01	488.00
HealthEquity	$1.31B	6.49	$215.20M	$2.77	37.20

Summary

HealthEquity beats Clover Health Investments on 12 of the 17 factors compared between the two stocks.

Get HealthEquity News Delivered to You Automatically

Subscribe Now

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding HQY and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.

HQY vs. The Competition

Export

Metric	HealthEquity	Healthcare Providers & Services Industry	Healthcare Sector	NASDAQ Exchange
Market Cap	$8.56B	$10.86B	$7.87B	$12.09B
Dividend Yield	N/A	2.54%	2.46%	4.50%
P/E Ratio	37.35	36.09	34.61	30.52
Price / Sales	6.52	2.19	8.89	5.88
Price / Cash	19.53	23.62	22.23	22.80
Price / Book	4.20	3.70	4.40	3.79
Net Income	$215.20M	$335.01M	$3.51B	$390.55M
7 Day Performance	-0.16%	-1.05%	-1.49%	-0.29%
1 Month Performance	14.71%	-1.18%	-3.90%	-6.63%
1 Year Performance	3.98%	19.77%	0.94%	-5.76%

HealthEquity Competitors List

Export

Company	MarketRank	Share Price	Analysts' Price Target	1Y Price Performance	Market Cap	Revenue	P/E Ratio	Employee Count	Indicator(s)
HQY HealthEquity	3.6977 of 5 stars	$103.46 +0.4%	$113.53 +9.7%	+2.5%	$8.56B	$1.31B	37.35	2,814	Positive News
ITGR Integer	0.4453 of 5 stars	$126.58 0.0%	$113.67 -10.2%	+82.2%	$4.30B	$1.85B	42.47	11,000
CNC Centene	3.9628 of 5 stars	$66.47 -2.9%	$73.80 +11.0%	+94.4%	$33.19B	$194.78B	22.76	61,100	Positive News Options Volume
MOH Molina Healthcare	2.38 of 5 stars	$208.57 +1.9%	$213.88 +2.5%	+48.5%	$10.34B	$45.43B	99.05	19,000	Analyst Revision
OSCR Oscar Health	4.4156 of 5 stars	$30.98 +2.0%	$34.90 +12.7%	+110.9%	$9.37B	$15.32B	22.13	2,305

Related Companies and Tools

Related Companies

Top 10 Stock Comparisons

This page (NASDAQ:HQY) was last updated on 11/13/2026 by MarketBeat.com Staff.

From Our Partners

Unlock superior investment research and tools.

Get MarketBeat All Access

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

HealthEquity (HQY) Competitors

HQY vs. ITGR, CNC, MOH, OSCR, and CLOV

How does HealthEquity compare to Integer?

Summary

How does HealthEquity compare to Centene?

Summary

How does HealthEquity compare to Molina Healthcare?

Summary

How does HealthEquity compare to Oscar Health?

Summary

How does HealthEquity compare to Clover Health Investments?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

HQY vs. The Competition

HealthEquity Competitors List

Related Companies and Tools

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

HealthEquity (HQY) Competitors

HQY vs. ITGR, CNC, MOH, OSCR, and CLOV

How does HealthEquity compare to Integer?

Which has stronger valuation and earnings, HQY or ITGR?

Do analysts recommend HQY or ITGR?

Is HQY or ITGR more profitable?

Does the media refer more to HQY or ITGR?

Which has more risk & volatility, HQY or ITGR?

Do institutionals & insiders believe in HQY or ITGR?

Summary

How does HealthEquity compare to Centene?

Do analysts recommend CNC or HQY?

Is CNC or HQY more profitable?

Do institutionals and insiders have more ownership in CNC or HQY?

Which has stronger earnings and valuation, CNC or HQY?

Does the media favor CNC or HQY?

Which has more risk and volatility, CNC or HQY?

Summary

How does HealthEquity compare to Molina Healthcare?

Do analysts prefer MOH or HQY?

Which has more risk & volatility, MOH or HQY?

Does the media favor MOH or HQY?

Do institutionals & insiders have more ownership in MOH or HQY?

Is MOH or HQY more profitable?

Which has better valuation and earnings, MOH or HQY?

Summary

How does HealthEquity compare to Oscar Health?

Which has more volatility & risk, HQY or OSCR?

Does the media prefer HQY or OSCR?

Which has stronger valuation & earnings, HQY or OSCR?

Do analysts prefer HQY or OSCR?

Do insiders & institutionals hold more shares of HQY or OSCR?

Is HQY or OSCR more profitable?

Summary

How does HealthEquity compare to Clover Health Investments?

Is CLOV or HQY more profitable?

Do insiders and institutionals hold more shares of CLOV or HQY?

Which has more risk & volatility, CLOV or HQY?

Does the media favor CLOV or HQY?

Do analysts rate CLOV or HQY?

Which has higher valuation & earnings, CLOV or HQY?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

HQY vs. The Competition

HealthEquity Competitors List

Related Companies and Tools

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools